-+ 0.00%
-+ 0.00%
-+ 0.00%

Rosenblatt Maintains Buy on Imax, Maintains $47 Price Target

Benzinga·02/26/2026 13:00:11
Listen to the news
Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and maintains $47 price target.